CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Tetraphase Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Davia Clinical Research | Tetraphase Pharmaceuticals | Tetraphase Pharmaceuticals, Inc | Tetraphase Pharmaceuticals, Inc. | TETRAPHASE PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2011

First marketed drug

Aug 27, 2018

First NDA

Aug 27, 2018

Last known activity

Mar 31, 2025

Acquired by Melinta Therapeutics on Mar 16, 2020

Timeline

2000s

  1. Jul 1, 2006

    Tetraphase Pharmaceuticals— Founded

2010s

  1. Aug 27, 2018

    eravacycline— NDA Organization

  2. Aug 27, 2018

    eravacycline— NDA Secondary Org

2020s

  1. Mar 16, 2020

    Melinta Therapeutics— Acquired By

Drugs by trial phase (7 distinct, 16 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (27)

Details

Founded
Watertown, MA, US Jul 1, 2006
First NDA
Aug 27, 2018
Last known activity
Mar 31, 2025

Designations held

  • Fast track
  • Priority review